000 | 00978 a2200265 4500 | ||
---|---|---|---|
005 | 20250515032637.0 | ||
264 | 0 | _c20060808 | |
008 | 200608s 0 0 eng d | ||
022 | _a1470-2045 | ||
024 | 7 |
_a10.1016/S1470-2045(06)70757-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGibson, Michael K | |
245 | 0 | 0 |
_aReassessment of the role of induction chemotherapy for head and neck cancer. _h[electronic resource] |
260 |
_bThe Lancet. Oncology _cJul 2006 |
||
300 |
_a565-74 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aNeoadjuvant Therapy |
700 | 1 | _aForastiere, Arlene A | |
773 | 0 |
_tThe Lancet. Oncology _gvol. 7 _gno. 7 _gp. 565-74 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(06)70757-4 _zAvailable from publisher's website |
999 |
_c16406723 _d16406723 |